The French stock Safran is currently traded with one the highest CAPE-ratios of the aerospace & defense companies. Currently the share is now traded at 140 times the past 10 year's average EPS. With this the stock trades significantly higher than the average US stock of the aerospace & defense companies which now costs 31 times the average 10-years EPS.
We further see that over the past year the American aerospace & defense companies yielded 3 percent higher. They performed worse than the European sector that yielded 3 percent higher. The American sector trades with a CAPE-ratio of 36 and the European sector trades at 22. The CAPE-ratios level doesn't seemt to have a relation with the price returns as the higher returns don't all have higher CAPE-ratios.
Over the current book year the total revenue will be 20,88 billion euros (consensus estimates). This is rather significant more than 2017's revenue of 16,94 billion euros.
The analysts expect for 2018 a net profit of 2,02 billion euros. For this year most of the analysts expect a profit per share of 4,76 euros. Based on this the price/earnings-ratio is 23,21.
For this year the analysts expect a dividend of 1,88 euros per share. The dividend yield is then 1,7 percent. The average dividend yield of the aerospace & defense companies is a moderate 1 percent.
Based on the current number of outstanding shares Safran 's market capitalization is 45,95 billion euros. The Safran stock was the past 12 months quite volatile. Since last November the stock is even 25 percent higher. This year the stock price moved between 81 and 122 euro. Since 2008 the stock price is almost 987 percent higher.
At 9.27 the stock trades 2,26 percent higher at 110,5 euros.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.